Oxybutynin and Omega-3 for OAB (Overactive Bladder)

NCT02070042 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Lack of participation

Conditions

Overactive Bladder

Interventions

DRUG: Omega 3 Fatty Acid
DRUG: Placebo

Sponsor

TriHealth Inc.